The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Third-line therapy and beyond for patients with advanced/metastatic non-small cell lung cancer (NSCLC).
Jesus Corral Jaime
No relevant relationships to disclose
Miriam Gonzalez de la Peña
No relevant relationships to disclose
Miriam Alonso
No relevant relationships to disclose
Amparo Sanchez Gastaldo
No relevant relationships to disclose
Maria Dolores Mediano
No relevant relationships to disclose
Marta Amerigo
No relevant relationships to disclose
Carlos Enrique Robles
No relevant relationships to disclose